ABCC11 expression (together with ABCB1) is responsible for resistant phenotype of breast cancer cell lines resistant to eribulin and inhibition of ABCC11 can partially restore the cross-resistance to 5-fluorouracil [33]. Here, ABCB1 is linked to breast carcinoma.